Home FTC Accuses Endo, Other Drugmakers of Antitrust Violations
 

Keywords :   


FTC Accuses Endo, Other Drugmakers of Antitrust Violations

2016-04-01 17:43:14| Biotech - Topix.net

The Federal Trade Commission has accused several drugmakers of violating antitrust laws, via agreements the commission said delayed the U.S. launches of cheaper generic versions of two popular pain treatments. It's the first so-called "pay for delay" case brought by the commission in which a drug's original maker agreed not to sell its own "authorized generic" version until well after a generic drugmaker began selling its product.

Tags: violations endo antitrust ftc

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
23.11Idées de CADRES No.83
23.11 12BOX PREMIUMpack 25th
23.11V2box
23.11
23.11 &
23.11DVD('97/)E11387
23.117
23.11
More »